A detailed history of Flaharty Asset Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Flaharty Asset Management, LLC holds 1,000 shares of AVXL stock, worth $10,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$10,870
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$4.11 - $7.04 $4,110 - $7,040
1,000 New
1,000 $5,000
Q3 2023

Nov 14, 2023

BUY
$6.55 - $9.37 $6,550 - $9,370
1,000 New
1,000 $6,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $847M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Flaharty Asset Management, LLC Portfolio

Follow Flaharty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flaharty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flaharty Asset Management, LLC with notifications on news.